Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products.

Siroli L, Patrignani F, Serrazanetti DI, Parolin C, Ñahui Palomino RA, Vitali B, Lanciotti R.

Front Microbiol. 2017 Feb 7;8:166. doi: 10.3389/fmicb.2017.00166. eCollection 2017.

2.

Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.

Shannon B, Gajer P, Yi TJ, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, Huibner S, Shahabi K, Ravel J, Kaul R.

J Infect Dis. 2017 May 1;215(9):1366-1375. doi: 10.1093/infdis/jix088.

PMID:
28201724
3.

Probiotics for vaginal health in South Africa: what is on retailers' shelves?

Happel AU, Jaumdally SZ, Pidwell T, Cornelius T, Jaspan HB, Froissart R, Barnabas SL, Passmore JS.

BMC Womens Health. 2017 Jan 19;17(1):7. doi: 10.1186/s12905-017-0362-6.

4.

Lactic acid bacteria differentially regulate filamentation in two heritable cell types of the human fungal pathogen Candida albicans.

Liang W, Guan G, Dai Y, Cao C, Tao L, Du H, Nobile CJ, Zhong J, Huang G.

Mol Microbiol. 2016 Nov;102(3):506-519. doi: 10.1111/mmi.13475. Epub 2016 Aug 18.

PMID:
27479705
5.

Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.

Nardini P, Ñahui Palomino RA, Parolin C, Laghi L, Foschi C, Cevenini R, Vitali B, Marangoni A.

Sci Rep. 2016 Jun 29;6:29024. doi: 10.1038/srep29024.

6.

Effects of Yeast and Bacterial Commensals and Pathogens of the Female Genital Tract on the Transepithelial Electrical Resistance of HeLa Cells.

Tsata V, Velegraki A, Ioannidis A, Poulopoulou C, Bagos P, Magana M, Chatzipanagiotou S.

Open Microbiol J. 2016 Apr 30;10:90-6. doi: 10.2174/1874285801610010090. eCollection 2016.

7.

Antimicrobial Stewardship and Urinary Tract Infections.

Abbo LM, Hooton TM.

Antibiotics (Basel). 2014 May 5;3(2):174-92. doi: 10.3390/antibiotics3020174. Review.

8.

Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.

Unlü C, Donders G.

J Turk Ger Gynecol Assoc. 2011 Dec 1;12(4):239-46. doi: 10.5152/jtgga.2011.57. eCollection 2011. Review.

9.

Vaginal microbiota of spayed dogs with or without recurrent urinary tract infections.

Hutchins RG, Vaden SL, Jacob ME, Harris TL, Bowles KD, Wood MW, Bailey CS.

J Vet Intern Med. 2014 Mar-Apr;28(2):300-4. doi: 10.1111/jvim.12299. Epub 2014 Jan 27.

10.

Differences in vaginal lactobacilli composition of Iranian healthy and bacterial vaginosis infected women: a comparative analysis of their cytotoxic effects with commercial vaginal probiotics.

Motevaseli E, Shirzad M, Raoofian R, Hasheminasab SM, Hatami M, Dianatpour M, Modarressi MH.

Iran Red Crescent Med J. 2013 Mar;15(3):199-206. doi: 10.5812/ircmj.3533. Epub 2013 Mar 5.

11.

Draft Genome Sequence of Lactobacillus gasseri Strain 2016.

Karlyshev AV, Melnikov VG, Kosarev IV, Khlebnikov VC, Sukhikh GT, Abramov VM.

Genome Announc. 2013 Aug 22;1(4). pii: e00624-13. doi: 10.1128/genomeA.00624-13.

12.

Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.

Zabihollahi R, Motevaseli E, Sadat SM, Azizi-Saraji AR, Asaadi-Dalaie S, Modarressi MH.

Daru. 2012 Oct 15;20(1):53. doi: 10.1186/2008-2231-20-53.

13.

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis.

Nouraei S, Amir Ali Akbari S, Jorjani M, Alavi Majd H, Afrakhteh M, Ghafoorian A, Tafazzoli Harandi H.

ISRN Obstet Gynecol. 2012;2012:375806. doi: 10.5402/2012/375806. Epub 2012 Oct 17.

14.

The advantages of second best: comment on "Lactobacilli vs antibiotics to prevent urinary tract infections".

Trautner BW, Gupta K.

Arch Intern Med. 2012 May 14;172(9):712-4. doi: 10.1001/archinternmed.2012.1213. No abstract available.

15.

Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.

Bradshaw CS, Pirotta M, De Guingand D, Hocking JS, Morton AN, Garland SM, Fehler G, Morrow A, Walker S, Vodstrcil LA, Fairley CK.

PLoS One. 2012;7(4):e34540. doi: 10.1371/journal.pone.0034540. Epub 2012 Apr 3.

16.

The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Mirmonsef P, Krass L, Landay A, Spear GT.

Curr HIV Res. 2012 Apr;10(3):202-10. Review.

17.

Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Dason S, Dason JT, Kapoor A.

Can Urol Assoc J. 2011 Oct;5(5):316-22. doi: 10.5489/cuaj.11214. No abstract available.

18.

Urinary tract infections in women: etiology and treatment options.

Minardi D, d'Anzeo G, Cantoro D, Conti A, Muzzonigro G.

Int J Gen Med. 2011;4:333-43. doi: 10.2147/IJGM.S11767. Epub 2011 Apr 19.

19.

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaya Y, Fiedler T, Cox M, Stamm WE.

Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14.

20.

The effects of commensal bacteria on innate immune responses in the female genital tract.

Mirmonsef P, Gilbert D, Zariffard MR, Hamaker BR, Kaur A, Landay AL, Spear GT.

Am J Reprod Immunol. 2011 Mar;65(3):190-5. doi: 10.1111/j.1600-0897.2010.00943.x. Epub 2010 Dec 9. Review.

Supplemental Content

Support Center